EHC · NYSE
Encompass Health Corporation
$124.01 -0.08 (-0.06%)
Company overview
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NYSE
- Market cap
- $12.2B
- Employees
- 28,572
- Headquarters
- Birmingham, AL
- Website
- encompasshealth.com
- CEO
- Mark J. Tarr
- Listed
- September 24, 1986
- P/E
- 20.40
- Dividend yield
- 0.66%
Company financials
- Revenue
- $6.1B
- Gross profit
- $3.6B
- Operating income
- $1.1B
- EBITDA
- $1.4B
- Net income
- $609M
- EPS
- $6.08
- Total assets
- $7.3B
- Total debt
- $2.8B
- Gross margin
- 58.82%
- Net margin
- 10.04%
- Earnings yield
- 4.90%
No geographic segmentation.
Showing FY 2025
EHC
1D
NYSE
O125.47H125.51L123.10C124.09-1.92 (-1.52%)Vol805.86K